← FDA DRUG APPROVALS

FDA ANDA · ANDA203762

LACTULOSE

Sponsor: SCIEGEN PHARMS

APPLICATION
ANDA203762
TYPE
ANDA
ORIGINAL APPROVAL
2015-03-27
LATEST ACTION
2021-08-16
ROUTE
ORAL, RECTAL, ORAL, RECTAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

LACTULOSEPrescription
LACTULOSE 10GM/15ML · SOLUTION · ORAL, RECTAL

Approval history

2021-08-16Manufacturing (CMC) · Supplement 4 · unknownAP
2015-03-27UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →